IBIO
NASDAQ
$1.37
iBio Inc (IBIO)
iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $5.40 (+294.16%)
Market Cap
$58M
Free Cash Flow Yield
-35.40%
Beta (5Y)
0.98
Price Chart
Valuation
Market Cap$58M
P/S279.86
P/B1.08
Profitability
Total Revenue (TTM)$100K
Gross Profit (TTM)$300K
EBITDA-$27M
Operating Margin-9653%
EPS-$1.29
Financial Health
Free Cash Flow Yield-35.40%
Growth & Risk
EPS 5Y CAGR-48.91%
FCF 5Y CAGR+7.46%
Beta (5Y)0.98
Sharpe Ratio1.05